@article{Andrey A Ivashchenko2020-09-13,
author = { Andrey A Ivashchenko,  Andrey A Svistunov,  Tatiana V Khorobryh,  Vladimir G Loginov,  Ruben N Karapetian,  Natalia P Mishchenko,  Stanislav V Poyarkov,  Maxim V Volgin,  Elena V Yakubova,  Michael P Topr,  Oleg V Pyankov,  Anastasia V Magerramova,  Alexey A Tomilov,  Alexandre V Ivashchenko},
title = {Aprotinin - a New Drug Candidate for The Prevention of SARS-CoV-2 (COVID-19)},
year = {2020},
publisher = {NP «NEICON»},
abstract = {The efficacy of Aprotinin as prophylactic treatment of Covid-19 was studied in the hamster model of SARS-CoV-2 and in the health care personnel working with Covid-19 patients in hospital. High efficacy of Aprotinin in pre- and post-exposure prophylaxis of SARS-CoV-2 was demonstrated.},
URL = {https://covid19.neicon.ru/publication/10269},
eprint = {https://covid19.neicon.ru/files/3946},
}